Skip to main content
OpenTrials

Clinical trial condition

Multiple Myeloma in Relapse

Explore clinical trials studying Multiple Myeloma in Relapse. Study availability and eligibility vary by location and protocol.

57 public trials 23 recruiting studies
Refine in advanced search Browse all conditions

Multiple Myeloma in Relapse trial results

Active, Not Recruiting

Study of HPN217 in Participants With Relapsed/Refractory Multiple Myeloma MK-4002 (MK-4002-001)

NCT04184050

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • The University of Kansas Cancer Center Fairway, Kansas, United States
View Trial Details
Active, Not Recruiting

Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma

NCT05673083

Conditions
Behavior, Blood Protein Disorders, Cardiovascular Diseases, +20 more
Locations
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • Cancer Specialists of North Florida Jacksonville, Florida, United States
  • Misson Cancer + Blood Des Moines, Iowa, United States
  • Hematology-Oncology Associates of Central New York East Syracuse, New York, United States
View Trial Details
Active, Not Recruiting

Ixazomib-pomalidomide-dexamethasone as Second or Third-line Combination Treatment for Patients With Relapsed and Refractory Multiple Myeloma Previously Treated With Daratumumab, Lenalidomide and Bortezomib

NCT04790474

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Emek Medical Center Afula, Israel
  • Rambam Medical Center Haifa, Israel
  • Hadassah Ein-Kerem Medical Center Jerusalem, Israel
  • Shearei Zedek Medical Center Jerusalem, Israel
View Trial Details

Related conditions